FDA Inspection
Recipharm MontsFDA Inspection 1181620 - Recipharm Monts - October 18, 2022
Record Details
This FDA Inspection record concerns Recipharm Monts, with an inspection on October 18, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
Open in Dashboard
ID · 1e8094d2-a501-42d5-a694-2a4acf3c64b3
Violation Codes9
21 CFR 211.113(b)21 CFR 211.160(a)21 CFR 211.166(a)(3)21 CFR 211.19221 CFR 211.22(d)21 CFR 211.42(c)(10)(ii)21 CFR 211.42(c)(10)(iv)21 CFR 211.42(c)(10)(v)21 CFR 211.68(b)
Full citation text and observation details available on the Dashboard.